Opaleye Management’s TG Therapeutics TGTX Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$19.3M	Hold	535,000	–	–	3.9%	8
2025 Q1	$21.1M	Sell	535,000 -1,725,000	-76%	-$68M	4.7%	8
2024 Q4	$68M	Sell	2,260,000 -20,000	-0.9%	-$602K	11.9%	2
2024 Q3	$53.3M	Hold	2,280,000	–	–	8.89%	2
2024 Q2	$40.6M	Hold	2,280,000	–	–	9.27%	2
2024 Q1	$34.7M	Buy	2,280,000 +65,000	+3%	+$989K	7.56%	3
2023 Q4	$37.8M	Buy	2,215,000 +325,000	+17%	+$5.55M	10.06%	2
2023 Q3	$15.8M	Buy	+1,890,000	New	+$15.8M	5.14%	4
2021 Q1	–	Sell	-387,500	Closed	-$20.2M	–	66
2020 Q4	$20.2M	Sell	387,500 -2,500	-0.6%	-$130K	2.63%	11
2020 Q3	$10.4M	Sell	390,000 -66,600	-15%	-$1.78M	2.04%	18
2020 Q2	$8.9M	Sell	456,600 -36,400	-7%	-$709K	1.8%	18
2020 Q1	$4.85M	Sell	493,000 -86,651	-15%	-$853K	1.29%	25
2019 Q4	$6.43M	Sell	579,651 -32,849	-5%	-$365K	1.26%	35
2019 Q3	$3.44M	Sell	612,500 -537,500	-47%	-$3.02M	1.24%	30
2019 Q2	$9.95M	Sell	1,150,000 -216,062	-16%	-$1.87M	3.03%	14
2019 Q1	$11M	Buy	1,366,062 +816,062	+148%	+$6.56M	3.04%	8
2018 Q4	$2.26M	Buy	550,000 +200,000	+57%	+$820K	0.84%	32
2018 Q3	$1.96M	Sell	350,000 -275,000	-44%	-$1.54M	0.5%	38
2018 Q2	$8.22M	Buy	625,000 +350,800	+128%	+$4.61M	2.13%	13
2018 Q1	$3.89M	Buy	+274,200	New	+$3.89M	1.11%	28
2016 Q3	–	Sell	-175,000	Closed	-$1.06M	–	51
2016 Q2	$1.06M	Sell	175,000 -240,000	-58%	-$1.46M	0.71%	44
2016 Q1	$3.54M	Buy	415,000 +115,000	+38%	+$980K	2.21%	20
2015 Q4	$3.58M	Buy	300,000 +40,000	+15%	+$477K	1.5%	29
2015 Q3	$2.62M	Buy	+260,000	New	+$2.62M	1.29%	32